Back to School: How biopharma can reboot drug development. Access exclusive analysis here

APC 366: To begin a Phase I trial in the U.K. in January

Arris Pharmaceutical Corp.

Read the full 30 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE